ARS Pharmaceuticals, Inc. SPRY Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s asset turnover?
- ARS Pharmaceuticals, Inc. (SPRY) reported asset turnover of 0.3× in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
- ARS Pharmaceuticals, Inc.'s asset turnover decreased by 8.0% year-over-year, from 0.4× to 0.3×.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s asset turnover?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s asset turnover has grown at a 79.2% compound annual growth rate (CAGR), from 0× to 0.2×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.